Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients
Open Access
- 1 January 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 167 (1), 205-213
- https://doi.org/10.1007/s10549-017-4495-y
Abstract
Ductal carcinoma in situ (DCIS) is associated with an excellent prognosis; historical studies have shown similar levels of psychological distress in patients with DCIS and with early-stage invasive breast cancer (early-IBC). It is suggested that these results might have led to better patient education about prognosis after DCIS. This study reports the current levels of anxiety, depression, and health-related quality of life (HRQoL) in DCIS and early-IBC patients. DCIS (n = 89) and early-IBC patients, T1-2N0, (n = 361) were selected from the UMBRELLA breast cancer cohort. Patient-reported outcomes were prospectively collected before the start of adjuvant radiotherapy (baseline) and at 3, 6, 12, 18, and 24 months thereafter. Mixed models were used to compare differences in levels of anxiety, depression, and HRQoL between DCIS and early-IBC patients. DCIS and early-IBC patients reported similar levels of anxiety, which were highest at baseline. Depression scores were comparable between groups, also after stratification by use of adjuvant chemotherapy. The proportion of patients reporting high-risk depression scores (i.e., Hospital Anxiety and Depression Sale score > 8) was significantly higher among patients with DCIS at 6, 12 and 18 months, and this proportion increased over the first 18 months. Health-related quality of life was comparable between both groups. Severe depression scores are more common in DCIS patients, despite their excellent prognosis. These results suggest that further improvement of patient education and effective patient doctor communication about the prognostic differences between patients with DCIS and invasive breast cancer is still highly needed.This publication has 34 references indexed in Scilit:
- Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controlsBreast Cancer Research and Treatment, 2012
- Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancerBreast Cancer Research and Treatment, 2011
- A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancerBreast Cancer Research and Treatment, 2010
- Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2010
- Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and OutcomesJNCI Journal of the National Cancer Institute, 2010
- Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancerBreast Cancer Research and Treatment, 2009
- A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situEuropean Journal of Cancer, 2007
- State Anxiety and Cancer-Specific Anxiety in Survivors of Breast CancerJournal of Psychosocial Oncology, 2004
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983